Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System

Valsts: Singapūra

Valoda: angļu

Klimata pārmaiņas: HSA (Health Sciences Authority)

Nopērc to tagad

Pieejams no:

BIOTRONIK ASIA PACIFIC PTE. LTD.

Klase:

Class D (contains therapeutic product or medicinal product)

Ražojis:

Biotronik AG

Ārstniecības joma:

Cardiovascular

Ārstēšanas norādes:

is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. The reference vessel diameter should closely match the scaffold nominal diameter. The treated lesion length should be less than the nominal scaffold length.

Produktu pārskats:

Device System Info:[Sterile Medical Device], sterile medical device by EO; Models: Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412526, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412529, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412527, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412530, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412528, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412531

Autorizācija datums:

2018-08-27

Meklēt brīdinājumus, kas saistīti ar šo produktu